Author:
Lindegren Mary Lou,Krishnaswami Shanthi,Reimschisel Tyler,Fonnesbeck Christopher,Sathe Nila A.,McPheeters Melissa L.
Publisher
Springer Berlin Heidelberg
Reference26 articles.
1. Agency for Healthcare Research and Quality (2008) Methods guide for effectiveness and comparative effectiveness reviews. AHRQ publication No. 10(12)-EHC063-EF. Agency for Healthcare Research and Quality, Rockville, MD, April 2012. Chapters available at:
www.effectivehealthcare.ahrq.gov
2. Blau N, van Spronsen FJ, Levy HL (2010) Phenylketonuria. Lancet 376:1417–1427
3. Burlina A, Blau N (2009) Effect of BH(4) supplementation on phenylalanine tolerance. J Inherit Metab Dis 32:40–45
4. Burton BK, Grange DK, Milanowski A et al (2007) The response of patients with phenylketonuria and elevated serum phenylalanine to treatment with oral sapropterin dihydrochloride (6R-tetrahydrobiopterin): a phase II, multicentre, open-label, screening study. J Inherit Metab Dis 30:700–707
5. Burton BK, Bausell H, Katz R, Laduca H, Sullivan C (2010) Sapropterin therapy increases stability of blood phenylalanine levels in patients with BH4-responsive phenylketonuria (PKU). Mol Genet Metab 101:110–114
Cited by
23 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献